-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Neutral on Aethlon Medical, Maintains $1.5 Price Target

Benzinga·08/14/2025 11:20:24
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Aethlon Medical (NASDAQ:AEMD) with a Neutral and maintains $1.5 price target.